Published in Mitochondrion on October 29, 2013
Mitochondria, cholesterol and cancer cell metabolism. Clin Transl Med (2016) 0.80
Individual-specific Variation in the Respiratory Activities of HMECs and Their Bioenergetic Response to IGF1 and TNFα. J Cell Physiol (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82
Predicting subcellular localization of proteins based on their N-terminal amino acid sequence. J Mol Biol (2000) 22.77
Blinded by the Light: The Growing Complexity of p53. Cell (2009) 17.75
On respiratory impairment in cancer cells. Science (1956) 14.07
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A (2005) 13.54
A mitochondrial protein compendium elucidates complex I disease biology. Cell (2008) 13.51
TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell (2006) 11.85
Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A (1996) 10.94
Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology (1997) 10.08
Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology (1998) 9.57
p53 regulates mitochondrial respiration. Science (2006) 9.06
p53 has a direct apoptogenic role at the mitochondria. Mol Cell (2003) 8.98
Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell (2003) 6.77
The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet (2003) 6.46
Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med (1995) 5.85
Characterization of the human heart mitochondrial proteome. Nat Biotechnol (2003) 5.66
Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci U S A (2000) 5.47
Energy metabolism in tumor cells. FEBS J (2007) 5.16
Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet (2007) 4.99
Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci U S A (2010) 4.99
A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J (1999) 4.68
Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. Cancer Res (2000) 4.66
Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer (2002) 4.57
Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nat Genet (2001) 4.23
Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc Natl Acad Sci U S A (2010) 4.18
MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J (1996) 4.13
p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell (2012) 4.11
FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination. Cell (2009) 4.11
Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem (2000) 4.11
Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells. Nat Protoc (2009) 3.65
MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nat Rev Cancer (2013) 3.60
P53 expression in breast cancer. Int J Cancer (1988) 3.51
Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochim Biophys Acta (2002) 3.34
Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene (2006) 3.17
Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene (2006) 2.96
DNA polymerase gamma, the mitochondrial replicase. Annu Rev Biochem (2004) 2.82
The human mitochondrial transcriptome. Cell (2011) 2.70
p53: new roles in metabolism. Trends Cell Biol (2007) 2.69
Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J (2007) 2.62
The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res (2004) 2.56
Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol Pharmacol (1998) 2.55
MdmX protects p53 from Mdm2-mediated degradation. Mol Cell Biol (2000) 2.50
Estrogen-receptor biology: continuing progress and therapeutic implications. J Clin Oncol (2005) 2.49
Dissecting p53-dependent apoptosis. Cell Death Differ (2006) 2.44
Estrogen receptors alpha and beta form heterodimers on DNA. J Biol Chem (1997) 2.39
Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. EMBO J (2005) 2.25
Mitochondrial localization of estrogen receptor beta. Proc Natl Acad Sci U S A (2004) 2.15
p53 and Nur77/TR3 - transcription factors that directly target mitochondria for cell death induction. Oncogene (2006) 2.04
Assembling the mitochondrial outer membrane. Nat Struct Mol Biol (2004) 2.00
Finding the right organelle. Targeting signals in mitochondrial outer-membrane proteins. EMBO Rep (2003) 1.97
The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev (2013) 1.93
Amphiphilicity is essential for mitochondrial presequence function. EMBO J (1988) 1.93
Senescence and aging: the critical roles of p53. Oncogene (2013) 1.90
Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol Endocrinol (1997) 1.90
p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res (2005) 1.88
Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human. Nucleic Acids Res (1998) 1.85
Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53. J Biol Chem (1997) 1.83
Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Mol Pharmacol (2005) 1.75
Internal targeting signal of the BCS1 protein: a novel mechanism of import into mitochondria. EMBO J (1996) 1.74
Axis of ageing: telomeres, p53 and mitochondria. Nat Rev Mol Cell Biol (2012) 1.74
Functional estrogen receptors in the mitochondria of breast cancer cells. Mol Biol Cell (2006) 1.72
Estrogen receptors and the metabolic network. Cell Metab (2011) 1.70
Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding. Mol Endocrinol (2008) 1.70
Transcriptional blockade induces p53-dependent apoptosis associated with translocation of p53 to mitochondria. J Biol Chem (2005) 1.67
CPEB regulation of human cellular senescence, energy metabolism, and p53 mRNA translation. Genes Dev (2008) 1.66
Mitochondrial localization of ERalpha and ERbeta in human MCF7 cells. Am J Physiol Endocrinol Metab (2004) 1.66
Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc Natl Acad Sci U S A (2001) 1.55
Oligomerization of BAK by p53 utilizes conserved residues of the p53 DNA binding domain. J Biol Chem (2008) 1.55
The biological role of estrogen receptors alpha and beta in cancer. Crit Rev Oncol Hematol (2004) 1.55
The Warburg effect in 2012. Curr Opin Oncol (2012) 1.54
Muscle GLUT4 regulation by estrogen receptors ERbeta and ERalpha. Proc Natl Acad Sci U S A (2006) 1.53
17beta-estradiol augments 18F-FDG uptake and glycolysis of T47D breast cancer cells via membrane-initiated rapid PI3K-Akt activation. J Nucl Med (2010) 1.53
False positives in MALDI-TOF detection of ERbeta in mitochondria. Biochem Biophys Res Commun (2006) 1.51
Wild-type and mutant p53 proteins interact with mitochondrial caspase-3. Cancer Biol Ther (2011) 1.49
Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes. Biochem Soc Trans (2005) 1.47
P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA. Cancer Res (2003) 1.44
Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function. J Biol Chem (2006) 1.44
p53 regulates mtDNA copy number and mitocheckpoint pathway. J Carcinog (2009) 1.43
Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis. Cancer Res (2007) 1.42
Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis. Mol Endocrinol (2007) 1.41
Estrogenic control of mitochondrial function and biogenesis. J Cell Biochem (2008) 1.37
Estradiol in vivo regulation of brain mitochondrial proteome. J Neurosci (2007) 1.36
p53 functions in the incorporation step in DNA base excision repair in mouse liver mitochondria. Oncogene (2004) 1.33
Incomplete arrest in the outer membrane sorts NADH-cytochrome b5 reductase to two different submitochondrial compartments. Cell (1994) 1.32
A comparison of transcriptional activation by ER alpha and ER beta. J Steroid Biochem Mol Biol (1999) 1.31
Regulation of AIF expression by p53. Cell Death Differ (2006) 1.31
p53 is cleaved by caspases generating fragments localizing to mitochondria. J Biol Chem (2006) 1.30
Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours. Br J Cancer (2006) 1.29
Homeostatic functions of the p53 tumor suppressor: regulation of energy metabolism and antioxidant defense. Semin Cancer Biol (2008) 1.27
A mitochondrial bioenergetic etiology of disease. J Clin Invest (2013) 1.27
Targeting p53 to mitochondria for cancer therapy. Cell Cycle (2008) 1.26
Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells. Cancer Res (2009) 1.26
Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. Biochim Biophys Acta (2009) 1.26
Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathway. Proc Natl Acad Sci U S A (2010) 1.26
Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy. Breast Cancer Res (2003) 1.26
Functional differences between the amino-terminal domains of estrogen receptors alpha and beta. Mol Pharmacol (2000) 1.24
Differential regulation of estrogen receptor alpha turnover and transactivation by Mdm2 and stress-inducing agents. Cancer Res (2007) 1.24
MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway. EMBO J (2009) 1.23
Mitochondrial impairment in p53-deficient human cancer cells. Mutagenesis (2003) 1.22